The vision to change the world
Life–changing therapy by global leaders in ophthalmology
Eyerising International is an Australian MedTech company developing life-impacting eye-health therapy to slow the progression of myopia. We are led by a team of world-renowned ophthalmology academics, researchers and a board with a proven track record in MedTech innovation, implementation, and clinical facilitation.
Patented childhood myopia control therapy
Eyerising International’s Myopia Management Repeated Low-Level Red–Light (RLRL) therapy was conceived and developed by ERI’s Chief Medical Officer, Professor Mingguang He, a global leader in myopia control and the development of artificial intelligence systems in ophthalmology. This innovation in childhood myopia control meets the quality, safety, and efficacy standards required by medical regulators in over 30 countries across Europe and Australasia.
View our most important scientific papers
A 12-month clinical trial conducted on 264 participants published on Ophthalmology
24-month follow-up clinical trial conducted on 199 participants published on CEO
Clinical trial to assess the efficacy and safety of treatment in controlling myopia progression compared to a sham device with only 10% of the original power published on Ophthalmology
A multicenter, randomized controlled trial (RCT) to evaluate longitudinal changes in macular choroidal thickness in myopic children treated for one year with the treatment published on Ophthalmology
Clinically Significant Axial Shortening in Myopic after RLRL
Axial Shortening in Myopic Children after Repeated Low-Level Red-Light Therapy
News and press releases
Milestone Alert!
We’re thrilled to announce a major achievement for Eyerising International: we’ve successfully reached 400 commercial patients using our Myopia Management Device outside of China! 🌍🎉 This milestone reflects our commitment to innovating and advancing myopia[...]
Eyerising Myopia Management Device Case study write up from New Zealand on NZ Optics!!!
Myopia management has fascinated me since my university days. So, after I graduated, I set up New Zealand’s first myopia management clinic in Hamilton’s Rose Optometry. Back in 2009 that was considered pretty unusual, as[...]
LIVE HEALTHIER LIVE LONGER
Exciting News! Dr. Maria Gina Go from the Philippines recently shared her insights on myopia and the benefits of the EyeRising Myopia Management device on the show "Live Healthier Live Longer." Don't miss out on[...]
Webinar Recap: Dr. Jason Yam and Dr Loren Rose on RLRL
We were thrilled to host an insightful webinar featuring the renowned Ophthalmologist, Dr. Jason Yam, on the topic of Repeated Low-Level Red-Light Therapy for patients with high myopia who are unresponsive to current treatments. A[...]
Tokyo Medical and Dental University Introduces the Eyerising Myopia Management Device for Their Myopia Patients
Melbourne, Australia - [July 9th, 2024] – Eyerising International is proud to announce that Tokyo Medical and Dental University will introduce the Eyerising Myopia Management Device for their myopia patients as part of their treatment[...]
Eyerising International is in Malaysia
We are proud partner with Transmedic to bring the Red Light #myopia management device to benefit Malaysian children suffering from myopia. Presenting at the WCPOS, a lot interests from clinicians. https://www.youtube.com/watch?v=GfFQqfbv-JM
Professor Mingguang He
Founder, Chief Medical Officer
Prof. He has over 25 years of experience in ophthalmology. He is currently a Professor of Ophthalmic Epidemiology at the University of Melbourne and leads ophthalmic epidemiology research at the Centre for Eye Research Australia. His research has led to original articles and invited editorials in respected medical journals, including the Journal of the American Medical Association, Diabetes Care, & Ophthalmology.
Jason Sun
Founder, MD
With a clinical background and over 20+ years of executive experience in the Australian health sector, including 10 years of industry development experience, Mr. Sun brings expertise in Medtech commercialisation, international business, regulatory compliance, and government relations.
Michael Woods
Executive Director
Mr. Woods has been an investor, adviser, board member, and CEO for various life science start-ups and scale-up companies in the life sciences sector.
Manny Pascual
Head of Commercial
Over 20 years of experience in the medical device industry Previous Marketing Director for CooperVision Asia Pacific Previous success in medical device company business expansion and acceleration.
David Holland
Business Development Manager (Australasia)
Federico Roma
CTO Accomplished technology leader
Dr. Yuri Aung
Clinical Affairs and RAQA Manager
Dr. Lisa Zhuoting Zhu
Director of Clinical Development
For any investor questions, please send your queries to:
Email: info@eyerisinginternational.com
Eyerising International Pty Ltd
Head office
Suite 2.05
9/11 Claremont St
South Yarra VIC 3141
